Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation
Clinical trial NCT05501756 · RECRUITING
Trial details
- NCT number
- NCT05501756
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-11
- Primary completion
- 2028-08-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.